Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofibromin 1 pseudogene 6 (NF1P6) is a processed pseudogene related to the NF1 gene, which encodes neurofibromin—a tumor suppressor protein[1][4][6][7]. Pseudogenes like NF1P6 arise from duplication and transposition events—NF1 pseudogenes on chromosomes 14 and 22 originated from larger duplications of the NF1 gene[3]. Pseudogenes are generally considered to be nonfunctional, lacking protein-coding capacity. However, some can exert regulatory effects via noncoding RNA transcripts, influencing gene expression or serving as microRNA decoys[5]. For NF1P6 specifically, there is no published evidence of protein expression, disease role, or direct interaction with drugs. Explanation of "is_incorrect": The query refers to NF1P6 as a "target molecule/receptor"; however, pseudogenes like NF1P6 do not typically encode functional proteins and are not considered therapeutic targets such as receptors, enzymes, or transporters[5]. Its naming and classification reflect its status as a pseudogene, not a functional target. There is no evidence in the literature that NF1P6 is misspelled, but there is insufficient evidence that this pseudogene meets the criteria for a druggable or disease-relevant biomolecule. Additional relevant context: - Neurofibromin (from the NF1 gene) is a GTPase-activating protein crucial for regulating Ras-MAPK signaling and acts as a tumor suppressor; mutations cause neurofibromatosis type 1 and other syndromes[1][4][6][7]. - Pseudogenes like NF1P6 are often retained in the genome but considered non-functional unless shown to affect regulation of parental genes or other pathways[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofibromin 1 pseudogene 6 (NF1P6).